<i>EIF1AX</i> and <i>NRAS</i> Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian CarcinomasDariush Etemadmoghadam, Catherine J. Kennedy, Sián Fereday et al.|Cancer Research|2017Cited by 91
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumorsMónica Tang, Michael Friedländer, Rachel O’Connell et al.|Gynecologic Oncology|2019Cited by 88
<i>BRAF</i> Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF InhibitionTania Moujaber, Anna DeFazio, Dariush Etemadmoghadam et al.|JCO Precision Oncology|2018Cited by 40